Archive for June, 2019
- The Green Organic Dutchman is building a name for itself as it works on production build-up from 2,000 kilograms of cannabis to 200,000 kilograms
- The company has facilities in Canada and is making inroads in Europe and Mexico through pharmaceutical networks
- In the United States, TGOD is finding access to the $20 billion functional beverage industry segment
The advent of indoor cultivation that’s suitable for the cannabis industry has changed the commercial production capacity of marijuana and medical-grade cannabis suppliers. While the cannabis plant seeks the sun during the height of summer then flowers as the season ebbs, indoor cultivation technologies are allowing producers to grow the plant with a sharply increasing lifestyle appeal during virtually any season of the year.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is making a name for itself as it pursues an upward scaling strategy of building enclosed facilities for cannabis growth, anticipating that its purpose-built enterprise will…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
CannabisNewsWire – TransCanna Holdings Inc. (CSE:TCAN) (XETR:TH8) today announces its placement in an editorial published by CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company for private and public entities in the cannabis industry.
To view the full publication, titled “Acquisitions Reveal the Steadily Changing Shape of the Cannabis Sector,” please visit: http://cnw.fm/G8nPH
The most eye-catching aspect of mergers and acquisitions in the cannabis sector is the amount of money that goes into them. Take just two recent examples from a single company, TransCanna Holdings Inc. (CSE:TCAN) (FRA:TH8).
In the past few months, the Vancouver-based cannabis company has made announcements on two major deals. First came the acquisition of a 196,000-square-foot vertically integrated cannabis facility for a total purchase price of $15 million. Then came a letter of intent relating to California company Lyfted Farms outlining TransCanna’s plans to acquire Lyfted’s business and assets for $5.5 million.
About TransCanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.
About CannabisNewsWire (CNW)
CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
A survey conducted by Gallup has found that the majority of Americans who are familiar with CBD (cannabidiol) want it available as an over-the-counter drug. The results of the survey were released on Friday last week (June 14).
The CBD craze traces its roots to the cannabis reform movement, and it gained momentum when the Farm Bill 2018 became law last year. This bill legalized industrial hemp and all its derivatives, including CBD.
The survey involving 1,017 participants was conducted over the phone in a bid to get insights into the widespread appeal of CBD. The interviews were conducted from May 15-30.
In all, 39 percent of the people polled revealed that they want to see CBD available as an OTC drug while 21 percent said CBD should be accessed using a doctor’s prescription. 36 percent of the people polled revealed that they weren’t familiar with this particular compound of hemp and marijuana plants.
When Gallup focused on those who were familiar with CBD and asked them whether CBD should be purchased as an OTC drug or as a prescription drug, 61 percent favored the OTC option while 33 percent preferred to see it as a prescription drug.
The participants in the poll were also asked to rate how familiar they were with CBD. 14 percent looked at themselves as “very familiar” with it, 33 percent felt they were “somewhat familiar”, 17 percent felt they were “not too familiar” while 36 percent confessed that they “weren’t familiar at all” with cannabidiol.
Gallup again narrowed its attention to only those who categorized themselves as very familiar with cannabidiol and asked them for their opinion about the medicinal value of CBD. 90 percent of this group believed that CBD had therapeutic benefits.
Of those who thought CBD had medicinal benefits, 33 percent said it had “a lot of benefits”, 45 percent felt CBD had “some benefits” and 14 percent thought cannabidiol had “a few benefits.” 3 percent were neutral on the matter while 4 percent said cannabidiol didn’t have any medical benefits.
Commenting about their findings, Gallup wrote that most Americans already believe that CBD has medicinal value even if research has been slow in proving or disproving many of the therapeutic benefits attributed to CBD. Gallup is convinced that the fraction of people who think CBD is medicinal is most likely to grow as more people get exposed to this non-psychoactive compound.
This possibility takes on a greater degree of certainty given that the FDA has already been convinced enough of CBD’s therapeutic benefits to the extent of approving a drug targeting rare forms of epilepsy.
The pressure on federal agencies like the FDA and Congress to pass laws legalizing CBD as a food supplement and other uses is therefore going to increase as the months go by.
Cannabis industry analysts are of the opinion that the Gallup findings didn’t catch industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) by surprise.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
New cannabis-infused products continue to hit shelves in major markets across North America, and into Europe. This has led to major competition among products on store shelves coming from branding and packaging innovators such as The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), Green Growth Brands (CSE:GGB) (OTC:GGBXF), Curaleaf Holdings, Inc. (CSE:CURA) (OTC:CURLF), Green Thumb Industries Inc. (CSE:GTII) (OTC:GTBIF), and 1933 Industries Inc. (CSE:TGIF) (OTC:TGIFF).Much of this new cannabis wave is derived from an increase in availability of cannabis products, gaining approval in major markets.
One such market is Oregon, where Statista projects to be worth nearly $1 billion by 2022. Recently, The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) received final packaging approval from the Oregon Liquor Control Commission (OLCC) for 6 Wright & Well cannabis topicals and tinctures to be distributed in the Pacific Northwest state.
The initial 6 approved Wright & Well products are Be Chill Tincture (THC: Purple Hindu Kush, CBD: hemp source); Be Better CBD Tincture (CBD: hemp source); Be Better CBD Extra Strength Tincture (CBD: hemp source); Be Relieved Pain Gel (THC: Purple Hindu Kush, CBD: hemp source); Be Free Pain Balm (THC: Purple Hindu Kush, CBD: hemp source); and Be Loved Massage Oil (THC: Purple Hindu Kush, CBD: hemp source)
“The OLCC packaging approval is one of the most rigorous processes to complete before products can be legally manufactured and sold in Oregon,” said Penny Green, CEO of Yield Growth. “Now that we have successfully completed the process, we have cleared the final hurdle, and we expect manufacturing to be complete in early July, and sales to begin in late-July.”
The products will be distributed in Oregon by Nova Paths, an Oregon-based cannabis licensed distributor that has established relationships with over 400 licensed cannabis retail stores. Targeted towards wellness-minded consumers, the products incorporate the highest quality CBD, THC, hemp root oil and terpenes to support a healthy lifestyle.
The approval came on the heels of the company’s previous announcement of a line of cannabidiol (CBD) W&W products in California.
Yield Growth has seized upon the global CBD market as a huge opportunity. A new study from BDS Analytics and Arcview Market Research projected this segment of the cannabis market alone could be worth $20 billion by 2024. This figure is a significant jump from estimated retail sales of CBD products in 2018, which ranged from $600 million to $2 billion.
In order to gain attention from new customers as this market continues to open up, targeted branding like that of Wright & Well products is needed. As giant mainstream retail chains such as CVS Health, Kroger, and Walgreens work towards carrying more cannabis-infused products on their shelves, it’s innovation from the products’ manufacturers that will likely be seen as being increasingly important through this cannabis revolution.
STRATEGIC ROLLOUTS OF NEW PRODUCTS
Getting products noticed requires creativity, and taking advantage of every potential platform. Capitalizing on a monthly subscriber base of over 3 million, The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) tapped beauty community ipsy, for its Urban Juve line of CBD-infused beauty products.
Urban Juve’s hemp root oil products became available for purchase on Shopper, ipsy’s ecommerce marketplace and will be featured in ipsy’s new product showcase, Glam Bag.
Urban Juve’s distribution goes far beyond ipsy, as it recently was announced for distribution of products in Greece and Cyprus. Overall the line has signed over 110 retail locations to sell its products in North America, and is now available through e-commerce sales in China, the US, Japan, South Korea and Germany.
The Urban Juve line of products continues to grow, with the latest announcement of its new line of CBD-infused skin care products, dubbed Urban Juve CBD Skin Essentials. The full-spectrum CBD products is expected to officially launch in the fall, using Urban Juve’s proprietary hemp root oil to maximize skin renewal. Urban Juve Skin Essentials will launch with two initial products: CBD Face Oil, CBD Facial Serum.
“Healthy, vibrant, glowing skin is the result of making right skin care choices,” said Bhavna Solecki, Director of Product Development at Urban Juve in the company’s accompanying press release. “Quality ingredients, thoughtfully formulated, ensure that your skin is nourished, supple and protected from environmental pollutants.”
The new Urban Juve CBD products are formulated with the rarest, cleanest, most ethical and most expensive oils in the marketplace-and with the added benefit of organic, full-spectrum CBD distillate and Urban Juve’s proprietary hemp root oil-the new products are unlike anything else on the market.
“We are seeing an incredible demand for CBD skin care products in the marketplace-from a wide range of customers. We’re poised to make significant inroads in this space because we had the foresight to formulate CBD-compatible products from the beginning. Currently, we are working on a catalogue of more than 200 formulations,” said Sandi Lesueur, President of Urban Juve. “We also have the right team in place. We have experience achieving massive growth for international cosmetics companies, so we are well-positioned to be a major force in the CBD skin care market.”
FURTHER CBD PERSONAL CARE DEVELOPMENTS
Green Growth Brands (CSE:GGB) (OTC:GGBXF)
Earlier in June, Green Growth Brands boasted it had surpassed the opening of 50 CBD shops in just four months. Under its Seventh Sense brand, GGB began opening these retail locations back in mid-February. The rapid roll out continued, as the company still projects to open more than 200 such shops by the end of 2019. Within these shops, Seventh Sense products consist of over 100 SKUs across bath, body, face, therapeutic, and sleep categories.
Curaleaf Holdings, Inc. (CSE:CURA) (OTC:CURLF)
With a supply deal with major US pharmacy chain CVS Health, Curaleaf has access to one of the most prominent retail shelves in the country. The deal is set to see Curaleaf’s hemp products sold in 800 stores in 10 states. Should that relationship expand, CVS has more than 9,800 sotres in the United States. In an effort to help with the development of new products of the future, Curaleaf has also agreed to sponsor the University of Connecticut for industrial hemp research.
Green Thumb Industries Inc. (CSE:GTII) (OTC:GTBIF)
Green Thumb products are not only being featured in third-party dispensaries and stores (including the luxury retail High End store from Barneys New York), but in the company’s retail chain, Rise. Green Thumb recently announced the opening of its fifth Rise retail location in Pennsylvania, dubbed Rise Latrobe. Among Green Thumb’s portfolio of assets, is the recently acquired Beboe branded products, out of California, which are available in more than 125 retail locations in California and Colorado.
1933 Industries Inc. (CSE:TGIF) (OTC:TGIFF)
Canadian cannabis company 1933 Industries is witnessing successes in its US distribution strategy. As of mid-June, the company’s premium Canna Hemp brand of CBD wellness products is available in more than 800 retail outlets across 46 US states. This includes more than 200 mainstream outlets carrying the brand, which consists of a portfolio offering over 70 high-quality, hemp-based, CBD-infused products with a range of specific effects.
Legal Disclaimer/Disclosure: While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing. Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of fifty thousand dollars for The Yield Growth Corp. advertising from the company. There may be 3rd parties who may have shares of The Yield Growth Corp. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. The owner/operator of Baystreet.ca has purchased shares of The Yield Growth Corp. through a private placement and does not intend on selling any shares within 72 hours of this updated publication date after such point we reserve the right to buy and sell shares in the open market, no further notice will be given. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing Baystreet.ca, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
TORONTO and SAN DIEGO, June 19, 2019 – Canopy Rivers Inc. (“Canopy Rivers“, the “Company”) (TSXV: RIV) (OTC: CNPOF) and ZeaKal, Inc. (“ZeaKal“) are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE: CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.
ZeaKal’s proprietary technology, PhotoSeed™, increases a plant’s intrinsic photosynthetic capacity, meaning that PhotoSeed™ plants can convert more sunlight and carbon dioxide into energy for growth. This results in substantial improvement in seed and grain yield, as well as improved macronutrient profiles that drive an increase in both oil and protein content. For farmers, this means better productivity and profit margins; for consumers, this means higher nutritional profiles and an environmentally friendly way to meet growing global demand. With multi-year field trials across diverse plant species in the United States, Canada and New Zealand, the initial commercial focus has been on major row crops. Following Canopy Rivers’ investment, ZeaKal intends to expand its program to include cannabis and hemp.
“Our investment in ZeaKal, the fifth consecutive international transaction for Canopy Rivers, builds on our thesis of selecting globally scalable and innovative processes, products, and technologies from complementary industries, and applying them to the cannabis and hemp economy,” said Mary Dimou, Director of Business Development at Canopy Rivers. “Plant sciences is a mostly overlooked but absolutely critical segment of the cannabis and hemp value chain, and we are seeking to address this gap with this investment. ZeaKal’s technology has already realized success across a number of crops during field trials, and these are crops that have been commercialized for decades. The application of this innovative technology throughout the Canopy Rivers portfolio and the cannabis and hemp industry at large could be a game changer.”
Canopy Rivers believes that ZeaKal’s PhotoSeed™ technology has the potential to translate into significant benefits for the cannabis and hemp industry. Due to prohibition, the cultivation of cannabis and hemp has lacked the agricultural research and advancements that have significantly improved the cultivation of other crops. Canopy Rivers believes that applying ZeaKal’s PhotoSeed™ technology to cannabis and hemp represents a significant step forward – with increased crop yield, higher oil production, additional grow cycles, and enriched cannabinoid output numbering among the potential benefits of the technology. While trials on cannabis and hemp have yet to begin, the positive results already achieved give Canopy Rivers confidence in ZeaKal’s experienced team and its ability to successfully optimize and adapt its technology for expansion into this industry.
“We are elated that Canopy Rivers, a cannabis and hemp industry authority, has selected ZeaKal as an agriculture partner,” said Han Chen, Chief Executive Officer of ZeaKal. “Beyond the capital, it is further validation that PhotoSeed™ is a next-generation blockbuster trait that can be utilized across diverse industries. With its rich domain and technical expertise, Canopy Rivers is supporting our entry into the cannabis and hemp markets with a technology we expect to be transformative for the sector.”
As a result of its US$10,000,000 investment, Canopy Rivers owns approximately 8.7% of ZeaKal on a fully diluted basis and holds an observer seat on ZeaKal’s board of directors.
About Canopy Rivers:
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.
About ZeaKal:
ZeaKal is a plant science company developed from the incubation pipeline of Kapyon Ventures in partnership with AgResearch Ltd. The company is focused on developing, PhotoSeed™, a next-generation trait technology that has been proven to increase the photosynthetic capacity and yield of several major crops.
Forward-Looking Statements
This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the application and benefits of ZeaKal’s PhotoSeed™ technology for a variety of crops and industries, including cannabis and hemp; the expansion of ZeaKal’s program to include cannabis and hemp; ZeaKal’s team and its ability to optimize and adapt the PhotoSeed™ technology for cannabis and hemp; the impact of ZeaKal’s PhotoSeed™ technology on Canopy Rivers’ portfolio, the cannabis and hemp industry, farmers and consumers; Canopy Rivers’ investment thesis; and other expectations regarding economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the actual application and benefits of ZeaKal’s PhotoSeed™ technology; changes in ZeaKal’s program; the performance of ZeaKal’s team and its ability to optimize and adapt the PhotoSeed™ technology for cannabis and hemp; the actual impact of ZeaKal’s PhotoSeed™ technology on Canopy Rivers’ portfolio, the cannabis and hemp industry, farmers and consumers; the ability of ZeaKal and Canopy Rivers to collaborate; opportunities for investment by Canopy Rivers; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- The Green Organic Dutchman is a premium, international organic cannabis company
- TGOD recently secured a cannabis supply agreement with Alberta Gaming, Liquor and Cannabis
- The company has a partnership with the world’s second-largest power-management company
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) grows high-quality, organic cannabis with sustainable, all-natural principles. A premium global organic cannabis company headquartered in Mississauga, Ontario, TGOD focuses on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD’s products are laboratory tested to ensure that patients have access to a standardized, safe, consistent product. The company’s organic process involves transparent, sustainable steps and principles to produce certifiable quality.
TGOD has a planned capacity of 219,000 kg and is constructing 1.64 million square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. Additionally, TGOD has organic hemp, CBD oil operations in…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced that it has hired Alan R. Applonie as general manager of its recently acquired 196,000-square-foot vertically integrated cannabis-focused facility in Stanislaus County, CA. Applonie will be responsible for all activities in the manufacturing operations of the facility, as well as other facilities and operations TransCanna may acquire in the area. “I’ve spent over six months interviewing for top-tier talent to oversee our operations and I firmly believe Alan is that person. Alan’s most recent position was for a multi-billion-dollar enterprise in which his division regularly produced greater than $300 million in annual revenues. He has decades of experience growing national brands and managing all aspects of supply chain and operations for CPG products. He has a deep and extensive understanding of manufacturing and processes, and is extremely results driven. We have no doubt he will add significant value to the TransCanna family of brands,” TransCanna CEO Jim Pakulis stated in the news release.
To view the full press release, visit: http://nnw.fm/Xb1sV
About TransCanna Holdings Inc.
TransCanna Holdings is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.
NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI) today announced its entry into an exclusive agreement with Feather Company Ltd., a cannabis innovator and lifestyle brand committed to the production of premium-quality products that enhance the cannabis experience for customers. Per the update, Organigram, through the Edison Cannabis Co. brand, has an exclusive license to Feather’s proprietary vaporizer pen technology and form factor, and the relationship will also allow Organigram to commercially represent Feather across Canada. “A successful recreational cannabis market requires that licensed producers and their partners continually reimagine the cannabis experience,” Organigram Senior Vice President, Marketing and Communications Ray Gracewood said in the news release. “It is critical for Organigram to find unique ways to offer customers the kind of value that will help differentiate our brands. The future is in providing unique opportunities for customers to explore the product.”
To view the full press release, visit: http://nnw.fm/1vKrZ
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.
NOTE TO INVESTORS: The latest news and updates relating to OGRMF are available in the company’s newsroom at http://nnw.fm/OGRMF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
SAN DIEGO, June 17, 2019 — Khrysos Industries, Inc. a wholly owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise announced today that it has entered into a 5 year Supply Contract with Magu Maiden Farms, LLC to provide extraction services and end-to-end processing to produce isolate, water soluble isolate, distillate, and water-soluble distillate hemp derived products. Extraction and post processing fulfillment and revenues are anticipated to begin in the fourth quarter of 2019 with revenues forecasted at $60 million through 2024 based on current market conditions and assuming, among other things, our ability to secure buyers for the produced product and the supplier’s ability to supply the biomass for extraction and processing.
“We are excited to add this new long-term contract to our portfolio. We have strategically targeted multiple long-term relationships that we believe places Khrysos in a stronger position to leverage the expansion taking place within the post processing area of our business,” said Dwayne Dundore PhD, President of Khrysos.
“We are very impressed with the Khrysos business strategy. This arrangement allows Magu Maiden Farms to concentrate on growing and expanding our operations, while Khrysos leverages its ability to implement extraction and post processing to our mutual best interests,” said Alan Nusbaum, President of Magu Maiden Farms.
Maria Rubiano, co-founder of Magu Maiden Farms said, “The Magu – Khrysos partnership is a win-win collaboration which will not only accelerate our growth this year, but should enable us to scale each year over the next 5 years.”
“The Khrysos Industries multi-dimensional distributed business model is gaining momentum,” said Dave Briskie, President and CFO of YGYI, about its wholly owned subsidiary Khrysos Industries. “The team at Khrysos has executed multiple projects including the buildout and move to our post processing facilities and the completion of our assembly operations. We continue to see that our Pre and Post Processing expertise, combined with the capabilities of our Analytical testing lab INX, provides a distinct competitive advantage within the Hemp Space.”
About Khrysos Industries, Inc.
Khrysos Industries is a leading manufacturer of commercial hemp-based CBD extraction, post processing equipment, and end-to-end processor of CBD isolate, distillate, water soluble Isolate, and water-soluble distillate. It’s subsidiary, INX Laboratories provides a broad range of testing services including potency analysis for its supply partners of hemp derived CBD products. Khrysos provides hemp growers, feedstock suppliers, and CBD crude oil producers the use of equipment, intellectual capital, production consultancy, tolling services, and wholesale CBD channel sales capabilities. Khrysos Industries was acquired by Youngevity International (NASDAQ: YGYI) on February 12th, 2019. Be sure to visit us at http://www.khrysosglobal.com, like us on Facebook <https://www.facebook.com/Khrysos-Industries-319252092134375/> and follow us on Twitter, or contact us at mailto:info@khrysosglobal.com.
About Youngevity International, Inc.
YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.
To receive future press releases via email, please visit: https://ygyi.com/investors/email-alerts/
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and includes statements regarding revenues beginning under the Supply Contract in the fourth quarter of 2019, revenues being forecasted at $60 million through 2024, and strategically targeted multiple long-term relationships placing Khrysos in a stronger position to leverage the expansion taking place within the post processing area of the Hemp business. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to commence revenues under the Supply Contract in the fourth quarter of 2019 and achieve revenues of $60 million through 2024, market conditions for hemp derived products remaining at current levels, our ability to secure buyers for the products we produce under the Supply Agreement, our ability to use our strategically targeted multiple long-term relationships to place Khrysos in a stronger position to leverage the expansion taking place within the post processing area of the Hemp business, and our ability to increase capacity and capabilities of the extraction technology, our ability to continue our international growth, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2018 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Contacts:
Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
800-982-3189 X6500
Investor Relations
YGYI Investor Relations
800-504-8650
investors@ygyi.com
Media Contact
Dwain Schenck
Schenck Strategies
203-223-5230
dwain@schenckstrategies.com
New York, NY – June 14, 2019 – Much has changed in the aftermath of the World Health Organization’s (WHO) marijuana reclassification recommendation back in February — in particular, the potential for the European Union (EU) CBD market. Products made from the non-psychoactive cannabinoid are growing in popularity in the EU, through innovation and perseverance from North American companies such as StillCanna Inc. (CSE:STIL) (OTCPK:SCNNF), Marijuana Company of America, Inc. (OTCQB:MCOA), ICC International Cannabis Corp. (OTCPK:WLDCF) (CSE:WRLD.U), OrganiGram Holdings Inc. (NASDAQ:OGI) (TSX.V:OGI) and Aleafia Health Inc. (OTCQX:ALEAF) (TSX:ALEF).
Europe’s CBD market potential is startlingly large. Leading market intelligence firm Brightfield Group predicts the estimated $318 million market (2018) to grow +400% through 2023 and be at least 2 times larger than the U.S. market. It’s an opportunity not lost upon producers, such as StillCanna Inc. (CSE:STIL) (OTC:SCNNF) that has already accumulated EU CBD assets in the UK, Romania, and Poland, leading to lucrative global supply deals.
Positive momentum for CBD and medical cannabis is growing, as the WHO recommendation was soon followed by a non-binding resolution voted on (and passed) by the European Parliament.
“CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited,” says Brightfield Managing Director, Bethany Gomez. “This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we’re seeing in the U.S. … CBD has been well received on a greater scale, especially in countries that already have medical or recreational cannabis programs and there are growing efforts in countries with no cannabis or CBD programs to have one or both in the coming years.”
So far, the largest CBD markets in Europe are in the United Kingdom and Austria, while Switzerland and Spain are building out and improving regulations surrounding product quality. With a population of more than 740 million people, the European market is home to more than double that of the combined populations of the United States and Canada.
Joining StillCanna Inc. (STIL-SCNNF) in the race to stake EU ground are companies both large and small, including both Marijuana Company of America, Inc. (OTCQB:MCOA), and ICC International Cannabis Corp. (OTCPK:WLDCF) (CSE:WRLD.U.CN) who have also gained ground in the UK.
Back in March, MCOA’s wholly-owned subsidiary hempSMART officially launched its industrial hemp-formulated CBD products in the UK.
Perhaps more diversified are the EU assets of ICC with cultivation, extraction, formulation and distribution assets in the UK, but also in Denmark, Poland, Switzerland, Germany, Greece, Italy, Portugal, Malta, and Bulgaria—which is likely set to become the first country in Europe to permit the sale of hemp-derived CBD nutraceutical products on the open market.
Other companies are finding their own entry-points into the EU market, such as OrganiGram’s (NASDAQ:OGI) (TSX.V:OGI) investment into Serbian-based Eviana Health Corporation to jointly produce high-potency CBD oils, pharmaceuticals, nutraceuticals, topical creams, and health products. In May, Aleafia Health Inc. (OTCQX:ALEAF) (TSX:ALEF) saw its shares get a boost upon announcing its entry into the German medical cannabis market through a joint venture with Acnos Pharma GmbH, a German pharmaceutical wholesale, in a market that’s still sorting out its own legality over the cannabinoid.
Leveraging the EU CBD Market
Back in May, StillCanna Inc. (STIL-SCNNF) signed a definitive agreement to supply Bioscience Enterprises of California with up to CAD$36 million worth of CBD isolate. The deal was the first major announcement after StillCanna had only officially acquired Polish hemp producer Olimax, just weeks prior.
The Olimax addition gave StillCanna a vertically-integrated licensed cultivator, extractor and formulator of CBD, and a team with a core strength of agriculture expertise with hemp. As well, the acquisition resulting in the planting of 1,500 hectares of land in Poland using the company’s proprietary hemp varietal, with an expected harvest in early August.
What the company does with that harvest will likely be even more impressive.
According to an April 2019 Hemp Benchmarks report, the wholesale price per kilogram for hemp isolate in the United States was $6,077 per kg. StillCanna has mastered the production process, to produce hemp isolate for a paltry CAD$500 per kg.
With a forecasted production potential estimated to eclipse 16,000 kg in 2019, the company’s forecasted production value can be expected to be more than $97 million—for an impressive profit margin of over 824%.
Beyond the Bioscience Enterprises of California deal, StillCanna has also secured a lucrative deal with UK-based Dragonfly BioSciences, LLC, which in March increased its monthly order to over 170 kgs per month for the next quarter. Now with a strategic relationship signed with Sarah Yetman, an expert in the international transportation of industrial hemp and CBD, StillCanna is looking to secure further international shipments and supply deals on a global scale.
“We are very impressed with the infrastructure that Sarah has been able to establish in both the USA and abroad,” stated Jason Dussault, CEO of StillCanna. “Her expertise and experience provides an invaluable service to StillCanna and is an important link in our supply chain. This relationship allows our products to reach a wider international audience. Ms. Yetman also brings a broad international base of buyers for both CBD products and hemp biomass.”
“I couldn’t be more pleased to be working with StillCanna and providing them with the global logistics they require,” said Sarah Yetman. “The contacts and infrastructure I have established is a custom fit for both the Company and myself. I look forward to implementing and overseeing the first of many shipments.”
As the EU and North American markets continue to liberate the potential of CBD, deals such as those expected from Sarah Yetman and StillCanna may shorten the distance between continents. Other producers are also looking to get into the EU’s CBD market, as it heads towards its predicted multi-billion-dollar potential.
Further European CBD Market Entrants
Through its wholly-owned subsidiary hempSMART, Marijuana Company of America, Inc. (MCOA) is producing industrial hemp-formulated CBD products for the UK market. In order to expedite the rollout of the hempSMARTTM product line in Europe, MCOA has taken steps to list the subsidiary on the Vienna Stock Exchange, ahead of entering Portugal, and later France, Germany, and Austria.
Having a presence in even more EU nations, ICC International Cannabis Corp. (WLDCF) (WRLD.U) including Denmark, Poland, Switzerland, Germany, Greece, Italy, Portugal, Malta, and Bulgaria. Truly built as an international entity to live up to its namesake, ICC is also looking to innovate how CBD is purchased. The Canadian company has acquired the rights to a self-dispensing THC/CBD vending machine, which is planned to be deployed into its existing network of 80,000 high-traffic retail endpoints and pharmacies across Europe.
Coming into the EU through a unique entry point (Serbia), OrganiGram Holdings Inc. (OGI) announced its private investment in Eviana Health Corporation. The Serbian-based Eviana creates high-quality, organic CBD from natural hemp strains of cannabis sativa. It operates on a parcel of 100 hectares of Serbian agricultural land, where it grows hemp. Due to the company’s license, OrganiGram gained easy access to the European market, and its significant demand for high-level CBD.
Aleafia Health Inc. (ALEAF) (ALEF) chose the high-potential medical cannabis market of Germany through a joint venture with pharmaceutical wholesaler Acnos Pharma Gmbh. Aleafia’s stock price bumped upward upon the announcement of entering the EU, and the potential for production of branded cannabis oils for distribution and for usage in clinical trials. The company’s expressed optimism to soon see the export of cannabis health and wellness products to the German market.
For a free research report on StillCanna Inc. (CSE:STIL) (OTC:SCNNF), visit www.potstocknews.com
Disclaimer: Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of StillCanna Inc.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.
Palm Beach, FL –June 14, 2019 — The cannabis marketplace is growing in every way every day. More dispensaries, more acres under cultivation, more products being ‘infused’, more mergers and acquisitions… and more and more news. Every day more articles and new revenue projection are released opining on what has happened, what is happening and what may happen. Perusing all this avalanche of info one common thread is obvious. The market will rise in 2019. There will be more product, more revenues, more infrastructure, more projections and more news. On such projection was made by Arcview Market Research, and was commented upon by various industry publications. One such summary said the following: “Global Marijuana Sales to Grow 38% to $16.9 Billion in 2019… Worldwide consumer cannabis spending should pick up big-time this year (2019)… (in 20018)… Canada had become the first industrialized country in the world to give the green light to recreational weed, paving the way for billions of dollars in legitimate annual sales, and pulling cannabis out of the shadows and into the spotlight as a valid business model… We also witnessed plenty of history made in the U.S., too. In December, President Trump signed the farm bill into law, legalizing hemp and hemp-based cannabidiol products throughout the country… Roughly two-thirds of all states have now legalized medical cannabis, with 10 of those states also allowing adult consumption. Active companies in the industry making moves to ready that include: Choom™ Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF), Fire & Flower Holdings Corp. (TSX-V: FAF) (OTCPK: FFLWF), National Access Cannabis Corp. (TSX-V: META.V) (OTCPK: NACNF), Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), MedMen Enterprises Inc. (CSE: MMEN.CN) (OTCQX: MMNFF).
The article continued with: “Another reason weed sales could soar in 2019 is the expectation that some supply kinks will work themselves out. As an example, California is likely to see its pot oversupply lessen as new legal dispensaries open for business. Meanwhile, Health Canada’s ability to power through a backlog of cultivation licenses and sales permits should allow more product to hit dispensary store shelves.”
Choom™ Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF) BREAKING NEWS: Choom™ unveils its retail concept and experience tomorrow in Niagara Falls, Ontario. As one of 25 cannabis stores authorized to open in the province, Choom Niagara provides a curated selection of premium products in an immersive environment designed to elevate and empower consumers.
In addition to holding distinction as Niagara Falls’ first cannabis store, Choom Niagara represents the brand’s debut retail presence in Ontario. With a store firmly established in the key Ontario market, Choom will continue its nationwide rollout, supporting the company’s overarching goal to secure one of the largest cannabis retail networks in North America.
Choom Niagara carries a diverse range of products, from dry flower and pre-rolls, to oils and capsules. All items are selected from a wide range of Canadian licensed producers, with the product portfolio strategically curated to ignite customer curiosity and encourage cannabis exploration.
Store associates have undergone stringent cannabis sommelier training, ensuring clients receive expert customer service customized to their specific needs. The store’s intuitive aesthetic, designed by commercial architect and interior design firm Hodgson Design Associates, achieves a relaxed and inviting environment, seamlessly guiding visitors through displays of THC-dominant, CBD-dominant and balanced products. Toronto businesswoman, Lisa Bigioni, was selected from a lottery of qualified candidates to own and manage the store.
“I’m delighted to serve the Niagara community, and can’t wait to hit the ground running,” said Bigioni. “My goal is for the store to become an indispensable resource for cannabis education and support for the local community. Choom’s extensive experience in regulated industries provides invaluable insight on store operations, and together we’ll deliver a cannabis retail experience the city can be proud of.” Read this and more news for Choom™ at: https://www.financialnewsmedia.com/news-choo/
Additional industry related developments from around the markets:
National Access Cannabis Corp. (TSX-V: META.V) (OTCPK: NACNF) recently responded to the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”) lifting the moratorium on new cannabis retail store openings in Alberta and has indicated that it will be releasing 5 retail cannabis retail licences per week. NAC expects to open one new retail location in Calgary on June 5 th, with an additional 10 built out stores throughout Alberta currently awaiting licensing.
“We’ve been waiting for this positive news from the AGLC,” said Mark Goliger , CEO of NAC. “We’re ready to open new stores throughout Alberta . We anticipate a new store opening in the Varsity neighbourhood in Calgary on June 5 th, with 18 additional licences submitted and 10 stores built out awaiting licensing and regulatory approval. Today, we have the largest footprint of retail cannabis stores in the province of Alberta , and Canada as a whole, and we’re working to maintain this position by continuing to aggressively pursue expansion opportunities in the early stage, and extremely high growth, cannabis industry.”
Fire & Flower Holdings Corp. (TSX-V: FAF.V) (OTCPK: FFLWF) recently announced the Company has achieved a milestone of C$25 million in system sales since opening on October 17, 2018 , the date adult-use recreational cannabis became legal in Canada . Today, the Company, through its wholly-owned subsidiary Fire & Flower Inc. operates 18 licensed cannabis stores in the provinces of Alberta and Saskatchewan and has licensed two branded shops in the province of Ontario .
“As the adult-use cannabis market continues to develop across Canada , this significant sales milestone demonstrates Fire & Flower’s ability to open and operate best-in-class retail stores across the country,” shared Trevor Fencott , Chief Executive Officer of Fire & Flower. “Our Hifyre digital platform including our Click & Collect service along with our retail experience team have been key drivers in achieving our level of sales.”
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) recently reported that it is partnering with Brookfield Properties to expand its CBD shop network in the U.S. The companies made a deal which allows GGB to open more than 70 prime shop locations at Brookfield’s shopping centers throughout the country. The move will further expand GGB’s physical footprint to approximately 280 total locations by the end of 2019. Brookfield owns, operates and develops office and multifamily assets in the U.S.
Peter Horvath, the CEO of GGB, states that Brookfield “operates some of the most exciting and visited malls in the country” and they are “thrilled to introduce our CBD shops to their centers.” “We know that consumers prefer to buy personal care and beauty products from physical stores, and this partnership will allow us access to millions of consumers,” Horvath notes.
MedMen Enterprises Inc. (CSE: MMEN.CN) (OTCQX: MMNFF) recently announced that will partner with Equality California, the largest statewide LGBTQ civil rights organization. During the month of June at all California stores, MedMen will donate 15% of proceeds from limited-edition Pride products to advance LGBTQ equality.
In addition, MedMen employees, friends, and family, including many in the LGBTQ community, will march on June 9th in the Los Angeles Pride Parade in support of the local community. MedMen’s first flagship store is in West Hollywood and the Company has five other locations throughout Los Angeles.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Wednesday announced that its wholly owned subsidiary, ABcann Medicinals Inc., has received notification of the advancement of its Kimmetts project to the second phase of Health Canada’s review and approval process. According to the update, the project is being developed as a hybrid outdoor cultivation site and currently houses four Airstream Innovations(TM) environmental control shelters with cultivation space of 86,000 square feet. “Our airhouses are expected to capitalize on all the benefits and opportunities associated with growing outdoors (low capital and production costs, environmentally sustainable) with the added benefit of mitigating against the known challenges of producing high-quality cannabis outdoors,” said Greg Yuristy, Director of Production for Napanee Operations. “The airhouses are intended to provide protection from the elements and a more consistent cultivation environment, and are expected to result in greater yields and more consistent high quality product than can be produced via outdoor growing. In addition, positive pressure keeps insects and weeds out, eliminating the need for pesticides.”
To view the full press release, visit: http://nnw.fm/oD0R3
About VIVO Cannabis(TM)
VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
LOS ANGELES, June 13, 2019 — via NetworkWire — Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) today announces it is finalizing negotiations for a series of strategic transactions that could reshape the California cannabis marketplace. Under the terms of the agreements, which are being negotiated and are not final, the Company will gain significant indoor, outdoor and greenhouse cannabis cultivation operations; an existing cannabis retail presence; a team of highly experienced cultivators and managers; and a direct cash infusion from a strategic investment group.
The transactions being negotiated are material and will result in a fundamental shift in the Company’s business, market value and ability to scale operations and cannabis assets under its control. In exchange for the acquired assets, the Company would issue a combination of restricted common and preferred shares to the strategic investment group and management team. In return, the strategic investors would make a direct cash investment and contribute significant operational and hard cannabis assets.
“We are in the final stages of negotiations, and once they conclude will be acquiring strong cannabis assets in the state of California,” commented Simon Yu, CEO, Cannabis Strategic Ventures. “Simply put, Cannabis Strategic Ventures would quickly become one of the largest cultivators in the state of California and the United States.”
Under the terms of the series of transactions, Cannabis Strategic Ventures is finalizing the following:
- Full funding for the Northern California-based NUGS Farm North, a 6-acre cultivation operation that is expected to produce multiple crops each year.
- The output of NUGS Farm North could reach an excess of 120,000 pounds per year.
- Planned distribution and manufacturing business operations at the NUGS Farm North location.
- Acquisition of downtown Los Angeles-based indoor cannabis cultivation operation assets focused on the production of premium cannabis.
- Licenses for manufacturing, distribution and retail for existing downtown Los Angeles operations.
- Downtown Los Angeles licensed retail assets with an established clientele base.
- Teams of highly experienced managers with specialties in cultivation, manufacturing and distribution focused on scaling downtown Los Angeles and NUGS Farm North operations.
- A direct capital infusion designed to allow the current and new corporate managers to effectively implement the enhanced business strategy.
Yu added, “While our level of confidence is high that we will successfully complete these negotiations, we still have a few final details to work out. Nevertheless, we believe the scale of this series of deals is significant enough for us to take this opportunity to inform our investors of the possibility of a potential fundamental shift in the overall scale of our operations and a meaningful positive impact on our overall corporate value.”
About Cannabis Strategic Ventures
Cannabis Strategic Ventures, Inc. is one of the largest publicly traded marijuana cultivators in the United States. The Firm is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.
FORWARD-LOOKING STATEMENTS: There is no assurance the contemplated transactions outlined herein will transpire. This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: IR@CannabisStrategic.com
Website: http://www.CannabisStrategic.com
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
NEW YORK, June 13, 2019 – via CannabisNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces the availability of an audio press release titled, “Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments.”
To hear the CannabisNewsAudio version, visit: http://cnw.fm/My9kX.
To read the full editorial, visit: http://cnw.fm/O5Oes.
|
A biotech company based in British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX:LXRP) is currently focusing on its proprietary DehydraTECH(TM) technology. This unique technology has been developed to make medicinal compounds more suitable for human consumption in a number of ways. By combining molecules such as CBD with fatty acids at a molecular level, DehydraTECH makes it easier for the CBD to cross the body’s internal barriers. Higher levels of CBD are absorbed, and they are absorbed more quickly.Consumers need to know this: the quantity of CBD, or any other drug, in the bottle is unimportant. What matters is how much of that CBD actually reaches the bloodstream — and even more importantly — how much reaches the brain.[LXRP study] results announced in May showed that DehydraTECH, in combination with generic nanotech techniques, delivered CBD to the brain 1,137% more efficiently than existing industry formulations. |
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About CannabisNewsWire (CNW)
CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.
For more information please visit https://www.CannabisNewsWire.com.
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
Palm Beach, FL – June 13, 2019 — CBD has been created one of the biggest growth stories of 2019 with consumers clamoring for products. Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. Barney’s will launch “The High End.” Even the Vitamin Shoppe just announced it’s selling CBD soft gels, and will soon begin selling CBD drops. Even the CEO of Whole Foods has indicated he’s keeping a close eye on cannabis regulation, suggesting that it could show up on shelves. In addition, according to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 – a compound growth rate of 147%. Some of the stocks benefiting from the cannabis market boom include Lifestyle Delivery Systems Inc. (CSE:LDS)(OTCQX:LDSYF), CannTrust Holdings Inc. (NYSE:CTST)((TO:CTST), and The Supreme Cannabis Company Inc. (TSX:FIRE)(OTCQX:SPRWF), Emerald Health Therapeutics Inc. (OTCQX:EMHTF)(TSX-V:EMH), and The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF).
Lifestyle Delivery Systems Inc. (CSE:LDS)(OTCQX:LDSYF) BREAKING NEWS: Lifestyle Delivery Systems Inc. announced that its flagship product CannaStrips has been delivered to multiple new stores. The Company has been diligently working on marketing strategies to increase the brand awareness of Cannastrips. The California market seems to be reacting to it quite well as almost every Cannabis event the Company has participated in has sold completely out of product. Cannastrips also won first place at the most recent Kushstock event. President of LDS Casey Fenwick has stated “the frequency of reorders has been steadily increasing as well as the order sizes. It is exciting to see we are moving through a healthy amount of product for a brand that has only been on the shelves for 4 months. I have been speaking with some of the larger California brands about branding collaborations, once the new website is finished, it will be a perfect time to finalize those and start the roll out.” The Company has been exploring with different printed mylar bags for the 10 packs in an effort to continually refine the amount of packaging labor. The style of printing as well as the arrangement of the state required legal information on the bag are being panel tested in order to perfect the aesthetics of the outer bag. The Cannastrips sales team is continuously performing vendor days in the stores and providing customers of the stores more information about the science of the product. For additional news for Lifestyle Delivery, please visit: https://www.lifestyledeliverysystems.com/lds-press-release
Other cannabis-related developments from around the markets include:
CannTrust Holdings Inc. (NYSE:CTST)((TO:CTST) released its financial results for the first quarter ended March 31, 2019, including record quarterly revenue of $16.9 million, a 115% increase over the first quarter of 2018, 67% was through the medical channel and 33% through the recreational channel. Total active patient count reached 68,000 at March 31, 2019, a 70% increase over the first quarter of 2018; Harvested production increased by more than 400% to over 9,400kg, versus the first quarter of 2018, and 96% over the fourth quarter of 2018; Sold over 3,000kg of dried cannabis equivalent, a nearly 200% increase over the prior year, at an average net price of $5.47 per gram.
“The CannTrust team delivered exceptional operational growth in the first quarter, with harvested production of over 9,400kg. This is a 96% increase in production over the prior quarter and reflects the impact of the investments made into our facilities, as well as process improvements to increase throughput,” said Peter Aceto, CEO. “With the successful closing of our equity offering providing gross proceeds of US$170 million (before exercise of the over-allotment option), we are well positioned to execute on our growth plans. Our fully-permitted Phase 2 expansion is expected to reach its full capacity of 50,000kg on an annual basis in the third quarter of 2019, and our 81 acres of land for outdoor cultivation has been prepared and we are awaiting regulatory approval to start planting. We have commenced work on our Phase 3 expansion in Niagara, which we expect will add a further 50,000kg of annual capacity. All told, we continue to expect to exit 2020 at a production rate of between 200,000kg to 300,000kg per year. This is a very exciting time for CannTrust and we plan to continue executing on our vision of becoming a global provider of innovative cannabis products and brands.”
The Supreme Cannabis Company Inc. (TSX:FIRE)(OTCQX:SPRWF) announced its financial and operating results for the three and nine months ended March 31, 2019. “Our Company is pleased with the results of our third quarter financials and with the progress made thus far on our strategic priorities for the 2019 calendar year. This quarter saw a marked increase in revenue on both an annual and quarter-over-quarter basis. This revenue growth was driven by an increase in our capacity at the 7ACRES facility, a ramping up of our product packaging capabilities and, we believe, consumer preference for high-quality cannabis,” said Navdeep Dhaliwal, CEO of The Supreme Cannabis Company, Inc.
“As we report the Company’s third quarter of fiscal 2019, we reflect on our first six months of legal cannabis sales in Canada. While Supreme Cannabis was originally viewed as a contrarian for taking a consumer-oriented approach to the cannabis market, 7ACRES’ strong consumer feedback, status as a top-ten revenue producer in the industry and recognition as a coast-to-coast award-winning premium brand affirms that our approach to the Canadian cannabis market is winning with the people who will drive revenue: consumers.”
Emerald Health Therapeutics Inc. (OTCQX:EMHTF)(TSX-V:EMH) has been appointed by the American Trade Association for Cannabis and Hemp (ATACH) to lead its International Affairs Council on CBD and Hemp in ATACH’s engagement with the US Food & Drug Administration (FDA) regarding policy pertaining to CBD-containing products and associated cross-border trade. The FDA is slated to begin public consultation on May 31 to discuss potential pathways for CBD products to come to market in the US. “Emerald Health Therapeutics is one of Canada’s original Licensed Producers and has expertise on CBD extraction and associated regulatory development,” said Michael Bronstein, President of ATACH. “We look forward to leveraging Emerald’s knowledge and experience as we participate in the FDA process on how to best navigate and implement a potentially-new regime for products containing cannabinoids in the United States.”
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF) just announced that it entered into a multi-year agreement with Neptune Wellness Solutions Inc. for extraction, formulation and packaging services. As part of the agreement, TGOD will have exclusivity on extraction, formulation and packaging of certified organic products within and for the Canadian market. Neptune’s expertise will enable TGOD to quickly scale up production of a wide range of consumer wellness products. Under the terms of the agreement, TGOD will allocate more than 230,000 kilograms of cannabis and hemp biomass for Neptune to process and transform into premium certified organic consumer wellness products, making this the largest deal for a processor in the industry to date. The contract between TGOD and Neptune covers a period of three years and is expected to be back-end loaded with the first year accounting for approximately 20% of the total value. It also marks a significant milestone for cannabis manufacturing in Quebec, creating high value jobs, complementing TGOD’s large investment in Valleyfield where the Company is nearing the completion of the first phase of what will become the world’s largest organic cannabis growing facility at over 1.3 million square feet.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM expects to be compensated twenty-five hundred dollars for news coverage of the current press release issued by Lifestyle Delivery Systems Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced that the company has granted incentive stock options under its stock option plan to certain officers to purchase a total of 1,263,000 subordinate voting shares, each at a price of $3.87. According to the update, subject to TSX Venture Exchange policies, the options are exercisable for a period of five years.
To view the full press release, visit: http://nnw.fm/A7cTR
About Canopy Rivers
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED) (NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://nnw.fm/CNPOF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- The company’s recreational cannabis plants and growing processes received organic certification from Pro-Cert Organic Systems Ltd.
- The certification is an important part of the company’s expansion strategy, as the market demand for organic cannabis products is on the upswing
- Organigram recently announced that it has secured a C$140 million credit facility with Bank of Montreal as the lead arranger and agent, which will largely be used to fund the company’s expansion plans and to refinance existing long-term debt
The end of May 2019 marked several exciting developments for Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), a leading Canadian licensed producer of medicinal and recreational cannabis products.
On May 31, Organigram announced that it has received organic certification for its recreational cannabis plants and growing processes. Pro-Cert, a North American certification body that is accredited to…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- Blade is a brand new, artificial intelligence-powered underwriting and merchant onboarding solution
- Due to the learning capabilities of AI software, the new solution will gradually become more effective, reducing decision-making time and bringing down the risk of errors
- Demand for artificial intelligence products for use in corporate environments is anticipated to grow rapidly, with financial service companies expected to spend over $11 billion on such products in 2020
Global technology and value-added solutions group Net Element Inc. (NASDAQ: NETE) is launching Blade – an artificial intelligence-based, fully-automated underwriting solution with predictive scoring, a company announcement noted (http://nnw.fm/yA8zT).
Blade is developed for underwriting and onboarding new merchants. The use of such an AI-powered solution brings down potential risks and decision-making time while also…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://nnw.fm/NETE
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
TransCanna Holdings (CSE: TCAN) (FSE: TH8), through execution of a nonbinding letter of intent to acquire the business and assets of Lyfted Farms Inc. of Modesto, California, is showing continued search for synergies and opportunities in the strategic move. An article discussing this reads, “The acquisition of Lyfted Farms would give TransCanna a finger in many pies. Lyfted Farms holds licenses from the state of California for nursery cultivation, commercial cultivation and distribution. The fast-growing company is well known in the California market. Presently, it offers a range of high-end flower that includes about 50 exotic and unique genetic strains, with cultivation managed by a team with over 20 years’ experience.”
To view the full article, visit: http://nnw.fm/JWjj2
About TransCanna Holdings Inc.
TransCanna Holdings is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.
NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NAPANEE, ON, June 12, 2019 – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company“) today announced that the Company’s wholly-owned subsidiary, ABcann Medicinals Inc., has received notification that its Kimmetts project has now advanced to the second phase of Health Canada’s review and approval process. Kimmetts is being developed as a hybrid outdoor cultivation site, which currently houses four Airstream InnovationsTM environmental control shelters with 86,000 square feet of cultivation space.
VIVO is the only Canadian LP employing this innovative technology, which has been incorporated in several US states to produce high-quality cannabis at low cost, without the capital investment required to build traditional greenhouses or indoor grows.
“Our airhouses are expected to capitalize on all the benefits and opportunities associated with growing outdoors (low capital and production costs, environmentally sustainable) with the added benefit of mitigating against the known challenges of producing high-quality cannabis outdoors,” said Greg Yuristy, Director of Production for Napanee Operations. “The airhouses are intended to provide protection from the elements and a more consistent cultivation environment, and are expected to result in greater yields and more consistent high quality product than can be produced via outdoor growing. In addition, positive pressure keeps insects and weeds out, eliminating the need for pesticides.”
“Subject to receipt of our license for the airhouses from Health Canada, we expect these initial four airhouses to provide annual production capacity of approximately 4,000 kilograms of cannabis, which we expect will be primarily used for VIVO’s concentrated products, which includes our premium cannabis brands of Canna Farms, Fireside, Lumina and Beacon, all of which are dedicated to enhancing the quality of life for our customers,” commented Gary McMullen, VP Napanee Operations. “Although our development plans are still being finalized, the Kimmetts site in Napanee has the potential to accommodate an additional 10 airhouses should cultivation results prove to be successful.”
About VIVO Cannabis™
VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, Fireside™, Canna Farms™ and Lumina™. The Company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information visit: www.vivocannabis.com.
ON BEHALF OF THE BOARD OF DIRECTORS
Barry Fishman
CEO and Director
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements regarding: the expected capacity expansion from the airhouses; the quality and consistency of the plants grown in the airhouses; and the expected cost and benefits of cultivating in the airhouses. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may not obtain final Health Canada approval for the Kimmetts project; that the Company may not be able to achieve its production capacity targets at the Kimmetts project; that the airhouses may not perform as expected; that the quality of the product obtained from the airhouses, and the cost thereof, may not be as expected; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company’s annual information form for the year ended December 31, 2018, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
NEW YORK, June 12, 2019 – via CannabisNewsWire – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company for private and public entities in the cannabis industry.
To view the full publication, titled “Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments,” please visit: http://cnw.fm/O5Oes
The popularity of cannabinoid products — those containing active ingredients from cannabis — has created a challenge for producers. While these producers are extracting larger volumes of CBD from cannabis and hemp, much of the precious ingredient goes to waste: the human body only absorbs a small fraction of these molecules because of delivery system limitations and human physiology.
Across the industry, researchers are looking for ways to more effectively deliver CBD into the human body. Thanks to their latest breakthroughs, the scientists at Lexaria Bioscience Corp. (CSE: LXX) (OTCQX:LXRP) appear to be leading the way.
Results announced in May showed that [LXRPs’] DehydraTECH, in combination with generic nanotech techniques, delivered CBD to the brain 1,137% more efficiently than existing industry formulations. In addition, Lexaria’s patented DehydraTECH delivered CBD into the bloodstream in just two minutes and delivered as much CBD in 15 minutes as generic doses did in 60 minutes.
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About CannabisNewsWire (CNW)
CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.
For more information please visit https://www.CannabisNewsWire.com.
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
Green Growth Brands continues to deliver on its rapid expansion strategy, targeting over 200 shops in operation by the end 2019
COLUMBUS, June 12, 2019 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or “the Company”) today announced that it has surpassed 50 Seventh Sense Botanical Therapy (“Seventh Sense”) shops open in four months. The first Seventh Sense shop opening was announced mid-February, and, since that time, GGB has continued to roll out its Seventh Sense shops at a rapid pace. The Company anticipates opening more than 200 such shops by the end of 2019.
Seventh Sense shops retail high-quality botanical therapy CBD-infused personal care and beauty products at affordable prices. The product offering includes over 100 SKUs across bath, body, face, therapeutic, and sleep categories.
“This rapid rollout across the U.S. is truly unprecedented,” said Peter Horvath, CEO of Green Growth Brands. “We expect to open over 200 shops this year and are confident that we are building one of the largest and most valuable distribution networks for CBD.”
In addition to the network of shops, earlier this year, Seventh Sense launched its eCommerce site, ShopSeventhSense.com, allowing consumers access to hemp-derived CBD personal care and beauty products online under the Seventh Sense Botanical Therapy brand.
A list of all current shop locations is available on ShopSeventhSense.com and is detailed below:
- Fayette Mall, Lexington, KY
- Glenbrook Square, Fort Wayne, IN
- Hamilton Place, Chattanooga, TN
- Castleton Square, Indianapolis, IN
- Oxmoor Center, Louisville, KY
- Mayfair, Wauwatosa, WI
- CherryVale Mall, Rockford, IL
- Providence Place, Providence, RI
- Emerald Square, North Attleboro, MA
- Las Vegas South Premium Outlets, Las Vegas, NV
- South Shore Plaza, Braintree, MA
- Penn Square Mall, Oklahoma City, OK
- Opry Mills, Nashville, TN (location #1)
- Opry Mills, Nashville, TN (location #2)
- King of Prussia, King of Prussia, PA
- The Streets at Southpoint, Durham, NC
- Arizona Mills, Tempe, AZ (location #1)
- Arizona Mills, Tempe, AZ (location #2)
- Park Place, Tucson, AZ
- Solano Town Center, Fairfield, CA
- Brea Mall, Brea, CA
- Tucson Mall, Tucson, AZ
- Greenwood Park Mall, Greenwood, IN
- Battlefield Mall, Springfield, MO
- Wolfchase Galleria, Memphis, TN
- Orland Square, Orland Park, IL
- University Park Mall, Mishawaka, IN
- Imperial Valley, El Centro, CA
- Colorado Mills, Lakewood, CO
- Park Meadows, Lone Tree, CO
- Chicago Ridge Mall, Chicago Ridge, IL
- Woodfield Mall, Schaumburg, IL
- Burlington Mall, Burlington, MA
- Arundel Mills, Hanover, MD (location #1)
- Arundel Mills, Hanover, MD (location #2)
- Concord Mills, Concord, NC
- Haywood Mall, Greenville, SC
- The Mills at Jersey Gardens, Elizabeth, NJ (location #1)
- The Mills at Jersey Gardens, Elizabeth, NJ (location #2)
- Auburn Mall, Auburn, MA
- Natick Mall, Natick, MA
- Philadelphia Mills, Philadelphia, PA
- Glendale Galleria, Glendale, CA
- Pioneer Place, Portland, OR
- The Shops at Mission Viejo, Mission Viejo, CA
- Northshore Mall, Peabody, MA
- Towson Town Center, Towson, MD
- Livingston Mall, Livingston, NJ
- Woodland Hills Mall, Tulsa, OK
- Fox River Mall, Appleton, WI
- Bay Park Square, Green Bay, WI
About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S., its CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. Learn more about our vision at GreenGrowthBrands.com.
About Seventh Sense Botanical Therapy
Seventh Sense Botanical Therapy offers CBD-infused botanical body care using the finest ingredients on earth. Crafted with wellness in mind, Seventh Sense aims to make CBD an accessible part of self-care routines across the country. Discover the magic of CBD at shops across the country and online at ShopSeventhSense.com.
Cautionary Statements:
Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies, including with respect to its retail shop strategy; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including without limitation, the expansion of GGB’s Seventh Sense brand, the expected access to new customers in premier retail locations and the expected opening date of the first GGB shop, is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.
The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.
Scientists from Leading Laboratories in Europe, Asia, Oceania, and North America Highlight the Critical Importance of PBI’s Patented PCT System in Cancer and Other Priority Research Areas
SOUTH EASTON, MA / June 12, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-base instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that the Company’s patented pressure cycling technology (“PCT”) platform was prominently featured in 15 independent presentations at the annual conference of the American Society for Mass Spectrometry (“ASMS”), held from June 1-6,2019 in Atlanta, GA. The presentations spanned wide ranging applications for PBI’s unique PCT platform in scientific studies, particularly their essential use in advancing knowledge and understanding in such areas as cancer research, protein function, molecular biology, and biomarker discovery.
Roxana McCloskey, PBI’s Global Director of Sales & Marketing, commented: “The number of PCT-related presentations at the 2019 ASMS conference significantly exceeded prior PBI records for a scientific meeting. We are gratified that the use of our PCT platform continues to expand to new investigators and laboratories worldwide, and that its use has shown great promise in critical areas of human health, such as cancer. We believe the presentations at this prestigious annual meeting clearly show the increasing potential for the PCT platform in diagnostics and discovery, which we believe could eventually lead to the routine use of the PCT platform in precision medicine, a rapidly expanding market that is expected to reach $217 billion by 2028 (BIS Research, 2019).”
PCT-related presentations delivered at the 2019 ASMS meeting were primarily in the following key areas.
Cancer Research
Nine presentations focused on the importance of PBI’s PCT platform in the study of cancers.Of these, three described the development and use of a novel, streamlined, sample preparation protocol and system featuring PBI’s Barocycler 2320EXT instrument and proprietary MicroTubes as the link between two widely used techniques: laser microdissection and mass spectrometry. In this new suggested system, precise small sections of cells are cut from suspected tumor tissue slices while being viewed under a microscope. Once cut from the biopsy tissue, the slices of interest fall directly into PBI’s MicroTubes, are processed by PCT and are then analyzed by mass spectrometry. Data show that the PCT platform has the potential to accelerate and strengthen protein analysis, improve cancer characterization, and provide clinically relevant information for diagnosis and treatment guidance in a timely manner. Findings also highlighted the necessity for the development of new methods and equipment for better identification of gynecologic cancers specifically, and cancer biomarkers in general.
Researchers from China and Australia reported on advancements in their cancer diagnostic programs. These large studies of thousands of cancer samples rely critically on PBI’s PCT platform to rapidly and reproducibly extract proteins from tumor tissues for analysis by mass spectrometry.
The PCT platform was also used in studies to better understand underlying racial disparities in cancer. Such studies may provide improved early detection and thus more effective treatment options to minorities.
Biomarker Discovery
Several presentations reported results from studies that used the PCT platform for basic research and discovery of unique cancer biomarkers. Discovery of new biomarkers for early diagnosis, cancer subtyping, progression, and underlying pathway dysfunction is vital to help improve clinical outcomes. In addition to cancer biomarker discovery, a presentation reported the use of the PCT platform to help reveal unique biomarkers due to exposure to chemicals in the environment such as benzene. This is the second report of using PBI technology to monitor the effects of environmental pollutants.
Protein and Molecular Biology Studies
The PCT platform continues to be used for basic but important proteomic research. The proteome consists of all the proteins made or modified by an organism. Studies presented of proteins, using PBI’s high pressure PCT system, included the use of pressure to accelerate enzymatic reactions for molecular biology and other applications, and for muscle tissue studies.
Richard T. Schumacher, President and CEO of PBI, said: “We are thrilled with both the number and caliber of presentations made at the annual ASMS conference highlighting the advantages of the PCT platform. Well-known research groups from both academia and industry, including key opinion leaders in proteomics and cancer diagnostics, presented data at the conference strongly supporting the use of the PCT platform in multiple areas of scientific research. These researchers were from highly respected labs and institutions worldwide, including: Johns Hopkins University, Fred Hutchinson Cancer Center, John P. Murtha Cancer Center, the Inova Schar Cancer Institute, Westlake University (China), Children’s Medical Research Institute (Sydney, AU), the ETH Zurich, PPD Madison, Pfizer, and SCIEX.”
Dr. Bradford Young, Sr. VP and Chief CommercialOfficer of PBI, said: “By 2025, the combined projected market sizes forcancer research, biomarker discovery, proteomics, and molecular biology isexpected to be in excess of $200 billion.The global proteomics market alone is projected to be in excess of $40 billionby 2025 (Zion Market Research, 2019). We believe the unique value provided by our PCT platform for samplepreparation and biomarker discovery as shown in the 15 presentations at this year’s ASMSConference will help generate awareness and demand for our platforms in these very largeand growing markets.”
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Investor Contacts:
Richard T. Schumacher, President and CEO (508) 230-1828 (T)
Bradford A. Young, PhD., MBA Sr. VP and CCO (508) 230-1829 (F)
Palm Beach, FL – June 12, 2019 – A recent article looking at what changes 2019 may bring to the global cannabis market projected that mergers and acquisitions will redefine the Marijuana Sector in 2019. Owners of well known brands, from alcohol to sunscreens, have seen that adding a CBD infused variety of their popular brands increases sales. Now everyone will want to have reliable sources to make sure they have enough supplies to meet the demand they hope will be coming in this year. The article said: “The cannabis sector is beginning to snowball and… the global legal cannabis market is predicted to be worth $146.4 billion by 2025… (companies) will have to compete with existing operators and other entrants interested in the ancillary cannabis sectors…” to lock up enough projected supplies of CBD to add to their product lines. Cannabis, alcohol and tobacco companies represent natural partnerships. Beverage companies are particularly interested in marijuana infused beverages, a market that is predicted to be worth $600 million in the US alone by 2022. Active companies in the industry making moves to ready that include: IONIC Brands Corp., (CSE: IONC), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX-V: OGI.V), Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), Planet 13 Holdings Inc. (CSE: PLTH.CN) (OTCQX: PLNHF), Cresco Labs Inc. (CES: CL.CN) (OTCQX: CRLBF).
The article continued: “As the global cannabis markets continue to grow and as the population continues to embrace CBD infused products, it is inevitable that non-cannabis companies with worldwide distribution networks will look to partner with cannabis companies to add CBD infused products to their existing brands. Companies like tobacco and alcohol may be some of the biggest players.” And they will be competing with all the other well established brand owners from dog food, coffee, edibles, lotions, non-alcoholic beverages, restaurants and all the other verticals wanting to get in on the ‘infusion’ train. It should be a heck of a ride!
IONIC Brands Corp., (CSE: IONC) BREAKING NEWS: IONIC Brands is pleased to announce that it has completed the acquisition of Vegas Valley Growers North (“VVG”) located in Las Vegas, Nevada, previously announced on April 2, 2019. VVG is a vertically-integrated, cash flow positive opportunity with a projected 2019 revenue of US$6.6 million, expected gross profits of US$3.1 million and EBITDA of US$2.0 million.
According to Arcview Market Research and Nevada State Department of Taxation, medical and adult-use spending on cannabis is projected to be over US$400 million in 2019 and US$500 million in 2020. Sales records were set during the first six months of 2018 where Nevada sold more than US$195 million in cannabis products compared to US$67 million in Washington State and US$114 million in Colorado in the same period.
IONIC BRANDS Chairman and CEO John Gorst commented, “The Nevada cannabis market is one of the cornerstone markets in the U.S. for building cannabis brands. With over 42 million visitors to Las Vegas per year, the VVG acquisition will provide our IonicTM vape and ZootsTM edibles brands valuable exposure to national and international cannabis consumers. The VVG acquisition includes the popular Nevada vape brand: “Vegas M Stick”. VVG offers Ionic Brands vertically integrated operations and distribution into over 75% of Nevada stores.” VVG’s CEO, Mitch Wilson commented that, “IONIC vape pens are the perfect complement to the Vegas M Stick. Together, these luxury brands are set to have a massive presence in the Nevada market for years to come.”
The VVG acquisition includes the lease for a 1,700 square foot production facility, situated on 3.42 acres of land. VVG is currently building a 60,000 square foot manufacturing facility with expected completion date of Q3 2019. A second 80,000 square foot facility is planned for Q4 2019. The VVG acquisition also includes four state licenses in hand for cultivation and manufacturing for both medical and recreational cannabis. The applications for the medical and recreational cannabis distribution licenses are being processed and are anticipated to be granted in Q2 2019. In 2018, VVG revenues were US$2.6 million, with an EBITDA of US$0.8 million. VVG’s flagship product is the Vegas M Stick and the Reno M Stick branded vape pens that have current market penetration of over 75% of stores in Nevada. The Company expects to increase sales of Ionic branded products by leveraging off VVG’s existing distribution pipeline and introduce various Ionic product SKUs to this distribution channel.
The total purchase price for VVG is US$8,870,000 (C$11,885,800) that includes a cash payment of US$7,620,000 (C$10,134,600), and 2,814,180 common shares of the Company at $0.5952 per share for an aggregate total value of USD $1,250,000 (C$1,675,000). The issuance of shares is subject to approval by the Board of Directors and the CSE. Read this entire announcement for IONC at: https://www.financialnewsmedia.com/news-ionc/
Additional industry related developments from around the markets:
OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX-V: OGI.V) a leading licensed producer of cannabis and extract-based products, recently announced it has been selected as one of the four Canadian launch partners of PAX Era, the premium oil vaporizer created by PAX Labs, Inc., a leading consumer technology brand in the design and development of premium vaporizers for dry flower and concentrates, when concentrates become legal in Canada later this year.
Much like Organigram’s own Edison Cannabis Co. brand, the PAX portfolio features disruptive, industry-leading technology, on course to redefine the experience of vaping in Canada – and around the world.
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) recently announced that it has acquired an option to purchase Emerald Bay Wellness LLC, a California-based cannabis oil manufacturer. The option grants PLUS the irrevocable right, but not the obligation, to purchase all of the business assets of Emerald Bay Extracts for cash and stock consideration.
“Acquiring Emerald Bay would give PLUS the opportunity to directly interact with the cannabis plant as we work to unlock the many benefits it is capable of delivering,” says Jake Heimark, Co-founder and CEO of PLUS. “We targeted this acquisition because it allows us to reap the benefits of vertical integration while maintaining a focus on product manufacturing. Beyond the benefits of internalization, we believe that the team at Emerald Bay, possess the professionalism and know-how to rapidly scale their wholesale oil business under our umbrella of resources. Ultimately, this is a rare opportunity to improve quality control, cut costs, and grow revenues all at the same time.”
Planet 13 Holdings Inc. (CSE: PLTH.CN) (OTCQX: PLNHF) a leading vertically-integrated Nevada cannabis company, recently announced it has signed a binding letter of intent (“LOI”) to acquire a cannabis sales license and lease for a dispensary (the “Dispensary”) in Santa Ana, California , a part of the Greater Los Angeles Region – home to 13.2 million people – from Newtonian Principles, Inc. (“Newtonian”). Planet 13 will pay Newtonian $6 million in cash and 2,039,808 Class A Restricted Shares valued at $4 million upon Planet 13 receiving final state and local regulatory approvals to transfer the operating entity after Newtonian opens its dispensary. As of March 31, 2019 , Planet 13 had $20 million in cash, leaving it well capitalized to execute on growth opportunities.
Cresco Labs Inc. (CES: CL.CN) (OTCQX: CRLBF) one of the largest vertically integrated multistate cannabis operators in the United States, recently provided an update on its acquisition (the “Transaction”) of CannaRoyalty Corp. d/b/a Origin House (CSE: OH-OTCQX: ORHOF).
Under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”), Cresco Labs is required to file a notification to U.S. antitrust authorities and observe a waiting period before completing the Transaction. On June 10, 2019, pursuant to the HSR Act, the Company received a request for additional information (the “Second Request”) from the United States Department of Justice Antitrust Division (the “Department of Justice”). The Second Request extends the HSR Act waiting period for up to 30 days after Cresco Labs and Origin House have each substantially complied with the Second Request, unless that period is extended voluntarily by the parties or terminated sooner by the Department of Justice.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by IONIC Brands Corp. by a non affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
- The TGOD contract represents the largest cannabis extraction deal publicly announced to date in Canada
- Neptune to create one-stop-shop for extraction, formulation and packaging
LAVAL, QC, June 12, 2019 – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), has entered into a definitive long-term agreement to provide extraction, formulation and packaging services to The Green Organic Dutchman Holdings Ltd. (“TGOD”) (TSX: TGOD) (US: TGODF). Neptune will extract and purify cannabinoids and terpenes from cannabis and hemp biomass received from TGOD. These extracts will be transformed into premium certified organic finished products.
Under the terms of the contract, TGOD has committed to supply more than 230,000 kilograms of cannabis and hemp biomass to Neptune spanning a three-year period. Volumes are expected to be back-end loaded with the first year accounting for approximately 20% of the total volumes of the contract.
Turnkey Solutions for New Product Forms
As part of this contract, most of the active ingredients extracted at Neptune’s Sherbrooke facility will be transformed into value added delivery forms onsite. Neptune will manufacture, package and provide formulation assistance, as required, in multiple product verticals to be sold under TGOD’s brands. Neptune will also formulate and package for TGOD capsules using its Licaps® technology licensed from Lonza. Health Canada is expected to authorize the sale of new product forms, including vape pens and infused food and beverages in fall 2019.
“We are excited to work with TGOD, an innovation driven company focused on value added and differentiated products,” said Jim Hamilton, CEO of Neptune. “The ambitions of each company are well aligned and we look forward to collaborating with TGOD, supporting their growth with new product forms.”
“TGOD’s commitment to organic and sustainability is inspiring; Neptune is proud to become a part of their success story. We are delighted that TGOD has placed its trust in our people and our technology with the largest deal the industry to date,” commented Michel Timperio, President of the Neptune’s Cannabis Division.
“With this agreement, Neptune becomes a key partner for TGOD; we have been impressed with their commitment to innovation and excellence in every aspect of their business. Their unique capabilities in terms of extraction, formulation and packaging were decisive factors in our selection process,” commented Brian Athaide, CEO of TGOD. “Today’s announcement is significant not only because it enables us to start manufacturing certified organic consumer wellness products at scale, but also because of the large and sustained economic impact it will have in Quebec where TGOD is building the world’s largest organic cannabis production facility.”
TGOD will work closely with Neptune’s team to assist them in obtaining their organic certification. To facilitate the certification process, Neptune will allocate a dedicated space to house and operate TGOD’s proprietary and/or licenced technologies. In addition, Neptune is in the process of achieving the EU-GMP certification, allowing TGOD to export products to other jurisdictions as laws and regulations permit.
The first shipment of biomass from TGOD is expected to be received by Neptune in September 2019.
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., is licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbooke, Quebec. Neptune brings decades of experience in the natural products sector to the legal cannabis industry. Leveraging its scientific and technological expertise, Neptune focuses on the development of value-added and differentiated products for the Canadian and global cannabis markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and of a variety of marine and seed oils. Its head office is located in Laval, Quebec.
Forward Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes”, “belief”, “expects”, “intends”, “projects”, “anticipates”, “will”, “should” or “plans” to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking information in this press release includes, but is not limited to, information or statements about Neptune’s ability to successfully, produce, or generate any revenue from the sale of any marijuana-based and hemp-based products under the terms of the agreement; the timing of Neptune’s or its partners’ anticipated results, including in connection with the likelihood and timing of obtaining all necessary regulatory approvals in connection with Neptune’s expansion at its licensed facility located in Sherbrooke; and the ability or failure of Neptune or its partners to comply with governmental regulations.
The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement and the “Cautionary Note Regarding Forward-Looking Information” section contained in Neptune’s latest Annual Information Form (the “AIF”), which also forms part of Neptune’s latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.html and on the investor section of Neptune’s website at www.neptunecorp.com. All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune public securities filings with the Securities and Exchange Commission and the Canadian securities commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under “Risk Factors”.
According to a new policy which has just been made public by Transport Canada (the federal transport regulator), flight crews as well as other industry employees will no longer be allowed to use marijuana within 28 days before they are due to fly.
The policy, which was announced on Thursday (June 6), takes immediate effect and it affects cabin crew, pilots and air traffic controllers. This policy was released in order to clarify the position of the regulator when recreational marijuana was legalized on October 17 last year.
Transport Canada asserted that aviation industry employees are required to maintain a certain minimum “level of fitness for duty” during the time when they are at work. Those employees must therefore refrain from using or being under the influence of any substance which can impair their faculties to a degree that can compromise aviation safety, the regulator added. Transport Canada also affirmed that their policy decision was informed by the current science available on the matter.
The announcement by Transport Canada isn’t altogether new in the Canadian aviation industry. The policy announcement comes after commercial airlines in the country, such as Westjet and Air Canada, had already issued blanket bans to their staff regardless of whether the employees wanted to consume recreational marijuana when they are off duty.
Speaking about Westjet’s radical policy on marijuana, the airline’s spokesperson said that the policy reflects the airline’s position as a leader in aviation safety, and that was why they were requiring Westjetters to report for duty while fit and stay that way throughout their shift.
Transport Canada has chosen to take the path similar to what the Department of National Defence decided to take on recreational marijuana. The military rules were updated to state that any serving military officer who wishes to use recreational marijuana should not do so within eight hours of starting their shift on duty.
The military rules also state that any personnel who operate weapons or vehicles aren’t allowed to consume recreational pot 24-hours before reporting for duty. Those that engage in high-altitude parachuting and those who serve on military aircraft are banned from using recreational cannabis in the 28 days prior to reporting for duty.
The Royal Canadian Mounted Police also announced earlier that any of its personnel who serve in “safety-sensitive positions” are prohibited from using cannabis 28 days prior to reporting for duty.
It would be interesting to know what companies like Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) think about these policies announced by aviation companies and regulators.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
Genprex (NASDAQ: GNPX), a clinical-stage, gene-therapy company, recently announced that it has retained pharmaceutical branding agency Addison Whitney to assist with the naming of the company’s leading drug candidate (http://nnw.fm/4arQW). An article further discussing the company reads, “Addison Whitney has a proven track record of branding success within the pharmaceutical market. It enables clients to achieve growth through both brand differentiation and creative naming practices. Its most recent successes include guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps needed for name approval. . . . According to Genprex Chairman and CEO Rodney Varner, retaining the services of Addison Whitney is an important step in bringing Oncoprex to market. Obtaining regulatory approval for the proprietary and non-proprietary drug names is one of the essentials for securing market approval, he explained. Varner said that he believes that Addison Whitney has an excellent reputation when it comes to securing such name approvals.”
To view the full article, visit: http://nnw.fm/NJy28
About Genprex Inc.
Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex immunogene therapy for non-small cell lung cancer. Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell-signaling pathways that cause replication and proliferation of cancer cells; re-establishes pathways for apoptosis, or programmed cell death, in cancer cell;, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
TORONTO, June 11, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce the voting results from its annual general meeting of shareholders of the Company (“Shareholders“), held in Mississauga, Ontario on June 11, 2019 (the “Meeting“).
All of the matters put forward before Shareholders for consideration and approval as set out in the Company’s management information circular dated May 9, 2019 (the “Circular“) were approved by the requisite majority of votes cast at the Meeting. In particular, Shareholders approved the election of all director nominees as follows:
|
Votes in Favour |
Votes Withheld |
% of Votes Cast in
Favour (rounded) |
| Brian D. Athaide |
13,528,485 |
326,150 |
97.65% |
| Jeffrey J. Scott |
13,363,648 |
490,987 |
96.46% |
| Marc Bertrand |
13,304,956 |
549,679 |
96.03% |
| Nicholas G. Kirton |
13,367,559 |
487,076 |
96.48% |
| Dr. Caroline MacCallum |
13,525,229 |
329,407 |
97.62% |
| Jacques Dessureault |
13,518,537 |
336,098 |
97.57% |
Shareholders also approved the following items of business before the Meeting: (1) the setting of the number of directors of the Company at six; and (2) the appointment of KPMG LLP as auditor of the Company for the ensuing year and the authorization of directors to fix their remuneration.
The total number of common shares of the Company (“Common Shares“) represented by Shareholders present in person and by proxy at the Meeting was 58,104,937 Common Shares, representing 21.12% of the Company’s total issued and outstanding Common Shares. Detailed voting results are available under the Company’s profile on SEDAR at www.sedar.com. A recording of the Meeting is available on the Company’s website at: https://www.tgod.ca/blogs/investor-news/webcast-tgod-agm-2019.
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD
The Green Organic Dutchman Holdings Ltd. is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly-owned subsidiary HemPoland distributes premium hemp CBD oil in EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica and Denmark.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company, the ability of the Company to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court, and other third party approvals in connection with the Arrangement, the ability of the Company to satisfy, in a timely manner, the conditions to the closing of the Arrangement, and other expectations and assumptions concerning the Arrangement. The anticipated timing provided herein in connection with the Arrangement may change for a number of reasons, including the inability to secure necessary regulatory, court, or other third party approvals in the time assumed or the need for additional time to satisfy the other conditions necessary to complete the Arrangement. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
- Anticipating Canadian legalization of adult-use cannabis edibles in October 2019, Organigram recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated chocolate line
- Production capacity is expected to be about 4 million kilograms per year of exceptional chocolate cannabis edibles
- The company’s chocolate launch is being led by a product development and production team with more than 25 years of combined chocolate experience and expertise
Canada is drawing closer to the legalization of edibles and derivative products, which is expected to occur this fall. As noted by Green Entrepreneur, edibles are expected to increase to 12-14 percent of the total cannabis market in Canada and the U.S. by 2022 (http://nnw.fm/J83cW). The pending rise of the edibles sector is good news for companies such as Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) that are positioning themselves to capture this further growth opportunity.
Organigram recently announced a C$15 million investment commitment for a state-of-the-art chocolate molding line and a fully integrated packaging line that includes advanced engineering, robotics, high-speed labeling and…
Read more »
NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
One of the biggest issues that has stood in the way of medical marijuana patients and healthcare professionals has been the challenge of how to determine the precise dosage to be administered in order to attain the required therapeutic effects. Additionally, it has been hard to find cannabis products whose potency is uniform in order to trigger repeatable outcomes in patients. To compound matters even further, CBD normally brings therapeutic effects at a certain specific concentration. Anything greater or lower than that optimum level reduces its efficacy. The marijuana industry has responded to these challenges by getting more clinical and scientific.
Stratos, a cannabis company based in Colorado, is one of those entities which have stepped up to provide medical cannabis products that are consistent in terms of potency. Their products are so precise that splitting a tablet in half is a guaranteed way to take just half of the dose indicated on the product label.
Charlotte Payton, the VP of Development and Co-founder of Stratos, revealed that the company leveraged the roots of its founders in the medical arena to find ways to bring the consistency which is a given in other industries to the medical cannabis space. She wondered why people would easily get reliability and consistency in pharmaceuticals but not cannabis. Strato’s solution addressed that issue.
GoFire is another healthcare technology company which is also blazing a trail in finding solutions to deliver consistency in the medical cannabis industry. One of the products which they have brought to market is called the GoFire Inhaler. The inhaler’s unique convection heating system, precision dosing mechanism and medical-grade materials and design have just been patented.
The inhaler made by GoFire was designed for medicines extracted from plants, so patients can use this product to take cannabis flower and concentrates. Buyers of the inhaler also get an app which allows them to track and document their dosage preferences in addition to connecting with a community of other users of the GoFire Inhaler.
The work of these two companies has been welcomed by both medical professionals and patients. One such professional who was full of praises for the inhaler is Denver-based Dr. Michael Keller. He said such devices help to ease some of the concerns that members of the medical community have about prescribing medical marijuana products. The possibility of recommending exactly how much a patient should consume at a given frequency brings medical marijuana closer to what is expected of any therapeutic product.
VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) applaud the innovations introduced by Stratos and GoFire since these technologies will bring medical cannabis closer to becoming a mainstream way to treat or manage different health conditions.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
